Why the study?
Does statin use improve survival in patients with community-acquired pneumonia admitted to the intensive therapy unit?
Does statin use improve survival in patients with community-acquired pneumonia admitted to the intensive therapy unit?
Answers are grounded in this paper and cite their sources.
Use of statins in community-acquired pneumonia (CAP) and exacerbation of COPD has been widely studied [ 1 – 3 ]. Whilst there may be some outcome benefit with the use of statins in exacerbation of COPD, their role in CAP remains less clear. There are no studies looking at outcome benefits from statin use in patients with CAP who are admitted to the intensive therapy unit (ITU). Therefore, we conducted a retrospective cohort analysis looking at statin use and outcomes in patients with CAP admitted to our ITU.
No takes yet. Share an insight, caveat, or question.
Khanna et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: